NSEInvestor Presentation4d ago · 3 Nov 2026, 08:12 pm

Investor Presentation

Laxmi Dental Limited · LAXMIDENTL

✦ AI SummaryResults

Laxmi Dental Limited has informed the Exchange about Investor Presentation for Q2FY27 and H1FY27 Earnings Conference Call on unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Laxmi Dental Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

LAXMI_03112026201100_Investor_Presentation.pdf

pdf

Download →
View document text
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com; co.sec@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: November 03, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Dear Sir(s)/Madam(s), Sub: Investor Presentation on Q2FY27 and H1FY27 Earnings Conference Call of Laxmi Dental Limited (“the Company”). Pursuant to Regulation 30(6) read with Para A Part A Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the copy of Investor Presentation for Q2FY27 and H1FY27 Earnings Conference Call on unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. The aforesaid shall also be available on the website of the Company i.e. https://www.laxmidentallimited.com/for-investors. Kindly take the above on record. Thanking you, For Laxmi Dental Limited -------------------------------------------------- Suman Saha Company Secretary and Compliance Officer ICSI Membership Number: A33035 Encl.: As above. LAXMI DENTAL LIMITED Investor Presentation November 2026 Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Laxmi Dental Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all-inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This Presentation contains certain forward-looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost overruns on contracts, our ability to manage our international operations, government policies and actions, regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward-looking statements become materially incorrect in the future or update any forward-looking statements made from time to time by or on behalf of the Company. Table of Contents 1 Slide 4 - 11 Q2 & H1 FY27 Performance & Financials Slide 4 - 11 2 Slide 12 - 29 Business Overview Slide 12 - 29 3 Slide 30 - 34 Historical Financial Statements Slide 30 - 34 4 Slide 35 - 36 Annexure Slide 35 - 36 Q2 & H1 FY27 Performance & Financials Management Messages Rajesh Vrajlal Khakhar Sameer Kamlesh Merchant Chairperson and Whole-time Director Managing Director and CEO “We are delighted to report another strong quarter, building on the positive start we made to FY27. “During Q2FY27, the Company delivered a strong performance across segments. For the Q2FY27 reported a highest ever quarterly revenue of INR 79.5 crore, taking H1FY27 revenue to INR quarter, our dental laboratory business grew by 22.7% year-on-year with robust growth in 154.2 crore. Growth was broad-based across our Dental Laboratory and Aligner Solutions international operations of 32.0% and healthy growth in domestic operations of 15.0%. businesses. EBITDA and PAT margins stood at 19.2% and 12.6%, respectively. Profitability remained healthy, supported by code dental product mix and continued operating discipline. This Aligner Solutions also delivered a strong growth of 23.5% year-on-year, driven by both Bizdent performance reflects our innovative strategies tailored to each region and business, alongside our and Vedia, with 27.7% and 19.1% year-on-year growth, respectively. Our paediatric business, continued focus on digitalisation and brand building. Kids-e-Dental, also continued to scale well with a year-on-year growth of 16.7%. Scanner sales for the quarter remained muted due to inflated prices for high-end laptops. We continue to During the quarter, our shareholders approved changes in the IPO use of proceeds, allowing INR evaluate our scanner roadmap in line with the overall market situation. 48.1 crore of unutilised proceeds to be redeployed, including INR 26.9 crore towards land and building for a company-owned, integrated dental laboratory and aligner facility. This is expected to Our performance reflects the strength of long-standing relationships with dental partners in enhance efficiency, strengthen cost control and support scalability. The transition will be in a India and overseas, supported by consistent execution across our sales and operations teams. phased manner to ensure service continuity without any material impact. We continue to invest in AI-led automation to make our operations faster, more consistent and efficient as we grow. Looking at the bigger picture, India’s dental industry is at an early stage of a structural shift. A highly fragmented lab market is gradually organising, dentists are adopting digital workflows, and In the Indian market we remain focused on increasing our wallet share with existing dentists patients are increasingly choosing quality, aesthetics and trusted brands. Globally too, demand for and adding new dental partners through our hub-and-spoke strategy and digitalisation. customised restorations has been rising, and dentists are increasingly turning to companies like Internationally, the strengthened on-ground leadership in the US, our participation at the Laxmi Dental that deliver superior quality and faster turnaround time at a competitive cost. upcoming International Dental Show (IDS) and the India–EU Free Trade Agreement concluded earlier this year are all expected to support our global expansion. Over more than three decades, Laxmi Dental has built the trust, quality systems, brands and infrastructure needed to lead this transition. We believe the decade ahead holds great promise for With continued progress in digitalisation, innovation, branding and network expansion, we dentistry in India and globally. We continue to build our capabilities to capture this opportunity remain well positioned to deliver sustainable and profitable growth in the years ahead.” responsibly and sustainably.” Consolidated Statement of Profit & Loss Consolidated P&L(INR mn) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY Q2 FY27 Performance Highlights Revenue from operations1 795.2 722.7 10.0% 747.0 6.5% 1,542.2 1,378.6 11.9% • Highest-ever quarterly revenue and [Showing first 8,000 characters — download PDF for full document]